BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7266469)

  • 1. Inhibition of 15-hydroxyprostaglandin dehydrogenase by 9,11-deoxyprostaglandins in vitro and in vivo.
    Yamazaki M; Ohuchi K; Sasaki M; Sakai K
    Mol Pharmacol; 1981 May; 19(3):456-62. PubMed ID: 7266469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 15-hydroxy prostaglandin dehydrogenase inhibitor on the degradation of prostaglandins through guinea pig lung lobes and in tracheal strips (author's transl)].
    Ishihara Y; Hayashi R; Hsu LH; Izumi T; Sugiyama Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):520-4. PubMed ID: 7420785
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of prostaglandin E1 from 15-ketoprostaglandin E1 by guniea pig lung 15-hydroxyprostaglandin dehydrogenase.
    Yamazaki M; Sasaki M
    Biochem Biophys Res Commun; 1975 Sep; 66(1):255-61. PubMed ID: 240360
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of 15-hydroxyprostaglandin dehydrogenase by papaverine.
    Iijima Y; Ueno T; Sasagawa K; Yamazaki M
    Biochem Biophys Res Commun; 1978 Feb; 80(3):484-9. PubMed ID: 204304
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on 15-hydroxyprostaglandin dehydrogenase from monkey lung.
    Sun FF; Armour SB; Bockstanz VR; McGuire JC
    Adv Prostaglandin Thromboxane Res; 1976; 1():163-9. PubMed ID: 826140
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of thromboxane B2 release from guinea pig lung during anaphylaxis following exposure to 100% O2.
    Crutchley DJ; Boyd JA; Eling TE
    Adv Prostaglandin Thromboxane Res; 1980; 8():1751-3. PubMed ID: 7377022
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Wu Y; Karna S; Choi CH; Tong M; Tai HH; Na DH; Jang CH; Cho H
    J Med Chem; 2011 Jul; 54(14):5260-4. PubMed ID: 21650226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein.
    Liu Y; Tai HH
    Biochem Pharmacol; 1985 Dec; 34(24):4275-8. PubMed ID: 4074386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressure.
    Parkes DG; Eling TE
    Biochem J; 1975 Mar; 146(3):549-56. PubMed ID: 167721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-Dehydroprostaglandins.
    Gandolfi C; Pellegata R; Ceserani R; Agresta G; Orsini G; Usardi MM
    Adv Prostaglandin Thromboxane Res; 1976; 1():209-14. PubMed ID: 998427
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of prostaglandin and thromboxane metabolism by successive immunological challenges in guinea-pigs [proceedings].
    Boot JR; Dawson W; Osborne DJ
    J Physiol; 1977 May; 267(1):27P-28P. PubMed ID: 874845
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypotensive prostaglandin structure activity relationships: 11-desoxy-16-aryl-omega-tetranor prostaglandins.
    Schaaf TK; Johnson MR; Eggler JF; Bindra JS; Constantine JW; Hess HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():313-8. PubMed ID: 6221542
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of endotoxin on 15-hydroxyprostaglandin dehydrogenase in the rabbit jejunum and lung.
    Blackwell GJ; Flower RJ; Herman AG
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):325-6. PubMed ID: 952587
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():347-9. PubMed ID: 7386273
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of an endogenous inhibitor of lung 15-hydroxyprostaglandin dehydrogenase.
    Bergholte JM; Okita RT
    Biochim Biophys Acta; 1986 Nov; 879(2):164-70. PubMed ID: 3768396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an anti-ulcer drug, plaunotol, and its metabolites on NAD+ dependent 15-hydroxyprostaglandin dehydrogenase from gastric mucosa.
    Oda T; Ushiyama S; Matsuda K; Iijima Y
    Life Sci; 1988; 43(20):1647-52. PubMed ID: 3193851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carbenoxolone on prostaglandin synthesis and degradation.
    Peskar BM; Holland A; Peskar BA
    J Pharm Pharmacol; 1976 Feb; 28(2):146-8. PubMed ID: 6674
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on 20-isopropylidene PGE2 as a new aerosol bronchodilator.
    Murao M; Uchiyama K; Shida A; Sakai K; Yusa T; Yamaguchi T
    Adv Prostaglandin Thromboxane Res; 1980; 7():985-8. PubMed ID: 7369064
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of leukotriene C4 output from rat isolated heart and lung by the sulphasalazine derivative Ph CL28A.
    Bakhle YS; Nakamura M; Pankhania JJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():113-6. PubMed ID: 1825528
    [No Abstract]   [Full Text] [Related]  

  • 20. N-(Methanesulfonyl)-16-phenoxyprostaglandincarboxamides: tissue-selective, uterine stimulants.
    Schaaf TK; Bindra JS; Eggler JF; Plattner JJ; Nelson AJ; Johnson MR; Constantine JW; Hess HJ; Elger W
    J Med Chem; 1981 Nov; 24(11):1353-9. PubMed ID: 6796685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.